Research Disclaimer
This article reviews published scientific literature for educational purposes only. All compounds referenced are sold by Blank Peptides exclusively for in-vitro research and laboratory use. Nothing in this article constitutes medical advice, a treatment recommendation, or an endorsement of human use.
Growth hormone is one of those compounds that exists in the space between genuine biology and gym mythology. GH secretagogues — peptides that trigger the body to release its own growth hormone — are more interesting than direct hormone replacement because they work with the body’s existing signaling. Ipamorelin and CJC-1295 are the most researched duo in this space.
Why Secretagogues Over Exogenous GH
Growth hormone is released by the anterior pituitary in response to two main signals:
- GHRH (growth hormone-releasing hormone) — from the hypothalamus, tells the pituitary “release GH now”
- Somatostatin — from the hypothalamus, tells it “stop releasing GH”
Exogenous GH bypasses this system entirely — flooding the bloodstream, suppressing natural release, and disrupting pulsatile patterns. Secretagogues enhance this system — more GH through your normal pituitary, pulsatile pattern preserved, feedback loops intact.
Ipamorelin: The Selective Ghrelin Mimetic
Ipamorelin is a pentapeptide that binds the ghrelin receptor (GHS-R1a). What distinguishes it from other GHRPs is selectivity:
- GH release — robust stimulation through physiologic ghrelin pathways
- Cortisol — no meaningful alteration (most GHRPs increase cortisol)
- Prolactin — no meaningful alteration
- Aldosterone — no meaningful alteration
- Appetite increase — expected side effect from ghrelin receptor activation (feature or bug depending on goals)
CJC-1295: The Extended GHRH Analog
CJC-1295 is a synthetic GHRH analog — mimics the hypothalamic signal that tells the pituitary to release GH, but with extended duration:
- Natural GHRH — half-life of minutes. Cleared quickly by normal metabolism
- CJC-1295 with DAC — half-life ~6-8 days via albumin binding. Sustained, consistent GH stimulation
- CJC-1295 without DAC — shorter half-life (~30 min). More precise timing, more frequent dosing
The Stack: Why They’re Used Together
Ipamorelin and CJC-1295 work on different parts of the same system:
- Ipamorelin — triggers GH pulse via the ghrelin receptor (the “go” signal)
- CJC-1295 — amplifies GH release via the GHRH receptor (the “amplifier” signal)
Research Applications
Body Composition
- Increased lean mass — GH drives protein synthesis rates
- Decreased fat mass — enhanced lipolysis (fat breakdown)
- Improved metabolic markers — glucose metabolism and substrate utilization
Recovery and Performance
- Tissue repair — GH supports protein synthesis and structural recovery
- Glycogen repletion — faster energy store restoration post-training
- Muscle preservation — reduced breakdown during caloric deficit or stress
Metabolic and Anti-Aging
- Blood sugar regulation — GH affects insulin sensitivity and glucose handling
- Age-related GH decline — secretagogues address somatopause through physiologic mechanism
- Bone density support — GH’s role in bone mineral maintenance
Safety Profile
The appeal of secretagogues is partly safety — by working with the body’s signaling rather than replacing hormones:
- Cleaner than exogenous GH — joint pain, carpal tunnel, insulin resistance risks substantially reduced
- Ipamorelin side effects — increased appetite (ghrelin activation), mild and expected
- CJC-1295 side effects — occasional flushing, transient
- Long-term data limited — most studies are short-term; inherent uncertainty about extended use
Browse These Compounds
Ipamorelin/CJC-1295 No DACIpamorelinCJC-1295 No DACCJC-1295 DACSermorelin